ProCE Banner Events

CE

Share

2023 PCE Oncology Spring Conferences – Hematologic Malignancies

PCE, the national leader in continuing education for NPs and PAs, returns this April with our virtual Spring Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Live streamed for your convenience and to allow access nationwide. Register now!

Nurse Practitioners/Nurses: 3.00 Nursing contact hours

Physician Assistants/Physician Associates: 3.00 AAPA Category 1 CME credits

This event has expired. No longer available for credits.

Credits Available

Attendees can earn 3.0 CE/CME credits, including pharmacology credit for NPs.

Who Should Attend

Oncology NPs, PAs, and RNs

Time and location

Saturday, April 29, 2023

9:00 AM - 2:10 PM Eastern Time (ET)

Virtual

Faculty
Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Andrew Kuykendall, MD

Assistant Professor
Department of Oncologic Sciences
University of South Florida
Assistant Member, Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, Florida

Caitlin Guerrero, MSN, RN, OCN, CNL

Nurse Director, Inpatient Oncology Research Program
Brigham and Women’s Hospital
Boston, Massachusetts

Agenda

8:30 AM – 9:00 AM ET Log-in

9:00 AM – 10:00 AM ET Non-accredited Presentation Theater: Intervene With Jakafi® (ruxolitinib) at the First Sign of Initial Systemic Treatment Failure in Chronic GVHD: A Real-World, Case-Based Discussion for Advanced Practice Professionals
Moderator: Katie King, BSN, RN, CPN, CPHON
Speaker: Linda Perry, MS PA-C

10:00 AM – 10:05 AM ET Welcome and Opening Remarks
Beth Faiman, PHD, CNP

10:05 AM – 11:05 AM ET A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review and Case Challenges Illustrating Current Therapeutic Standards
Andrew Kuykendall, MD

11:05 AM – 12:05 PM ET Navigating the New Advances in CAR T-Cell Therapy: Clinical Applications for Nursing Practice
Caitlin Guerrero, RN

12:05 PM  – 1:05 PM ET Non-accredited Presentation Theater: Real-World Case Discussion: When to Intervene With Jakafi® (ruxolitinib) In Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
Moderator: Patricia Manea, BSN, RN, OCN
Speaker: Maria Wood, DMSc, PA-C

1:05 PM – 2:05 PM ET Current and Emerging Novel Approaches to the Management of Patients with CLL/SLL and MCL
Beth Faiman, PHD, CNP

2:05 PM – 2:10 PM ET Summary and Closing Remarks
Beth Faiman, PHD, CNP

CME/CE Info

Target Audience
Oncology NPs, PAs, and RNs

Learning Objectives:

  • Identify efficacy and safety evidence supporting the use of novel therapies in hematologic cancers
  • Design individualized treatment plans for patients with hematologic cancers based on disease risk and tolerability of therapeutic approaches
  • Appropriately manage AEs of novel available therapies in hematologic cancers

Accreditation

Per Topic


Joint Accreditation Statement


In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.


AAPA Credit Designation


Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Supported by educational grants from AstraZeneca, Bristol-Myers Squibb, CTI BioPharma Corp, GSK, and Incyte Corporation.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act  - N/A virtual only
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.